Caitgem-Rtu 200 mg/5.26 ml Infusion belongs to the group of anti-cancer drugs called cytotoxics used alone or in combination with other anti-cancer drugs to treat various types of cancers like breast cancer, pancreatic cancer, non-small cell lung cancer, bladder cancer, and ovarian cancer. Cancer is the uninhibited and uncontrolled growth of cells in the body.

Caitgem-Rtu 200 mg/5.26 ml Infusion contains Gemcitabine which works by interfering with the synthesis of DNA, thereby causing cell death and arresting the uncontrolled production of new cells. Thus, Caitgem-Rtu 200 mg/5.26 ml Infusion is very effective in controlling cancer cells from multiplying and is used in the treatment of various types of cancers. 

A healthcare professional will administer Caitgem-Rtu 200 mg/5.26 ml Infusion. Do not self-administer. Caitgem-Rtu 200 mg/5.26 ml Infusion may cause certain common side effects such as nausea, hair loss, skin rash, vomiting, and oedema. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist. 

It is advisable to inform the doctor if you are allergic to any of the components. Consult your doctor if you are pregnant, planning to get pregnant, or breastfeeding. Talk to your doctor if you are planning to father a child before taking Caitgem-Rtu 200 mg/5.26 ml Infusion; your doctor may advise you regarding sperm storage. Avoid taking alcohol with Caitgem-Rtu 200 mg/5.26 ml Infusion.

Caitgem-Rtu 200 mg/5.26 ml Infusion is an anti-cancer drug used in the treatment of various types of cancers. Caitgem-Rtu 200 mg/5.26 ml Infusion is used either independently or in conjunction with other chemotherapy medications to treat breast cancer, pancreatic cancer, non-small cell lung cancer, bladder cancer, and ovarian cancer. Caitgem-Rtu 200 mg/5.26 ml Infusion works by interfering with DNA synthesis. It blocks the production of new DNA, by locking itself into the DNA strands and inhibiting any further proliferation or growth of the cell. Hence, Caitgem-Rtu 200 mg/5.26 ml Infusion has widespread application in the field of oncology (cancer-related medicine) and chemotherapy.

Caitgem-Rtu 200 mg/5.26 ml Infusion should not be used in case of any known allergy to any of the components. Caitgem-Rtu 200 mg/5.26 ml Infusion should be used with caution in case of high risk or previous history of heart disease, vascular disease, liver problems, kidney disease or alcoholism. Keep your doctor informed if you suffer from any shortness of breath, kidney problems, hypertension diabetes or epilepsy. Avoid Caitgem-Rtu 200 mg/5.26 ml Infusion during pregnancy and breastfeeding. Offer a detailed medical history, vaccination history, and inform the doctor especially if you are on any radiotherapy.

• Discuss contraception with your doctor while taking Caitgem-Rtu 200 mg/5.26 ml Infusion.
• Men are advised not to father a child during and up to 6 months of treatment with Caitgem-Rtu 200 mg/5.26 ml Infusion. In case of any concerns, please discuss them with your treating doctor. 
• You may want to consider sperm storage before starting Caitgem-Rtu 200 mg/5.26 ml Infusion. Seek counsel on the same from a qualified healthcare individual and/or sperm bank. 
• In case of any flu-like symptoms such as fever or chills, please consult your doctor before taking any antipyretic medications or paracetamol.